"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...

Hyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...

The Nifty50 made a reversal candlestick chart pattern on the daily charts indicating that market is lacking momentum and further up move fr...

The Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.

Private equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.

Indian markets are expected to trade in a range. Here is a list of fifteen stocks which are likely to remain in focus today.

At 10:00 a.m.; Sensex was at 8,265.65, down 1.1 points or 0.01 per cent. It touched a high of 8,286.40 and a low of 8,255.35 in trade today.

Indian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.

Bayer will completely take over the marketing and distribution of the consumer care products with effect from January 1, 2015, it added.

The government is committed to making India one of the world’s leading destinations for end-to-end drug discovery and innovation by 2020.

Launch of patented drugs in India could be delayed due to the government's "thought process on linking patented drug prices to the country'...

Piramal bought DRG from private equity firm Providence, which exited the company by selling its 100% holding.

Cadila Healthcare today said its consolidated net profit rose by 50.69 per cent to Rs 178.97 crore for the fourth quarter ended March 31, 2...

A leading UK-based company is all set to buy Ahmedabad-based Paras Pharmaceuticals, a person close to the development said.

Emami, which has shown a keen interest in Paras Pharma ever since the beginning of the bidding game, is understood to be shelling out aroun...

Ranbaxy Laboratories Ltd, India's biggest drugmaker, considers acquisitions aimed at expanding operations in the US, south and central Amer...